Sai Life Sciences Ltd

SAILIFE
NSE· Healthcare
₹1,272.10
+7.10 (+0.56%)
Updated 12:40 pm IST
52W Low · ₹778.5052W High · ₹1,288.00
Near 52W High
Market Cap
₹25165.39L Cr
Volume
5.48L
Prev Close
₹1,265.00
ISIN
INE570L01029

VestAI Stock Score

VALUATION
Low Debt
D/E 0.12x — lean balance sheet
QUALITY
Average
ROCE 16.6% — decent returns
MOMENTUM
Neutral
RSI 66.6 — consolidating

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
72.47
ROCE
16.63%
ROE (1Y)
15.13%
D/E Ratio
0.12x
OPM
21.80%
TTM EPS
₹16.37
Dividend Yield
0.00%
Qtrly Sales
₹602.14 Cr
Qtrly Profit
₹104.24 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹602.14₹104.2421.8%₹4.87
Q3 2026₹556.46₹100.3825.8%₹4.71
Q1 2026₹496.42₹60.4516.8%₹2.83
Q4 2025₹579.51₹88.2720.7%₹4.14
Q3 2025₹439.78₹53.8519.5%₹2.84

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2026₹2,192.49₹348.91₹672.2921.2%
FY 2025₹1,694.57₹170.13₹442.4415.8%
FY 2024₹1,456.47₹82.81₹314.5812.4%
FY 2023₹1,196.95₹9.99₹192.96.4%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
SAILIFE ★₹25,165 Cr72.4716.63%15.13%0.12x21.80%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹90,029 Cr25.9412.55%9.93%0.21x15.11%
ABBOTINDIA₹57,724 Cr36.6336.14%34.46%0.04x27.01%
AJANTPHARM₹41,836 Cr39.5527.99%25.39%0.06x51.40%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹3,159.97₹2,275.14₹2,186.65₹2,164.23
Equity₹2,128.36₹975.14₹888.09₹878.57
Total Debt₹352.38₹927.66₹932.38₹965.45
Cash₹91.12₹23.66₹69.91₹115.94
Net Debt₹37.52₹686.51₹629.32₹635.38
Working Capital₹772.02₹205.21₹205.1₹230.78

Shareholding Pattern

Q1 FY2027

Promoter
38.09%
FII
22.84%
DII
18.69%
Public
20.38%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202738.09% ↑22.84% ↑18.69% ↓20.38% ↑
Q3 FY202634.7% ↓21.41% ↓31.41% ↑12.49% ↓
Q2 FY202634.95% ↓22.5% ↑29.92% ↑12.65% ↓
Q1 FY202635.15%14.57% ↑21.64% ↑28.64% ↓
Q4 FY202535.16% ↓12.36% ↑13.26% ↑39.21% ↓
Q3 FY202535.23%11.72%11.95%41.08%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

127 mutual fund schemes

1
DSP Healthcare Fund Direct GrowthDSP

6.86%

₹227 Cr

2
Invesco India Business Cycle Fund Direct GrowthINVESCO

5.17%

₹62 Cr

3
Invesco India Large & Mid Cap Fund Direct GrowthINVESCO

4.89%

₹547 Cr

4
Invesco India Smallcap Fund Direct GrowthINVESCO

4.89%

₹656 Cr

5
Nippon India Pharma Fund Direct GrowthRELIANCE

3.43%

₹296 Cr

6
Nippon India MNC Fund Direct GrowthRELIANCE

3.39%

₹14 Cr

7
Mirae Asset Healthcare Fund Direct GrowthMIRAE_ASSET

3.23%

₹100 Cr

8
Invesco India Mid Cap Fund Direct GrowthINVESCO

3.20%

₹441 Cr

9
WhiteOak Capital Pharma and Healthcare Fund Direct GrowthWHITEOAK_CAPITAL

3.17%

₹21 Cr

10
Kotak Healthcare Fund Direct GrowthKOTAK_MAHINDRA

2.90%

₹16 Cr

Analyse SAILIFE with Orion AI

Ask: "Is Sai Life Sciences Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Sai Life Sciences Ltd (SAILIFE) Stock

Sai Life Sciences Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE570L01029. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.